WO1999053950A3 - Live vaccines and methods of treatment therewith - Google Patents
Live vaccines and methods of treatment therewith Download PDFInfo
- Publication number
- WO1999053950A3 WO1999053950A3 PCT/US1999/008530 US9908530W WO9953950A3 WO 1999053950 A3 WO1999053950 A3 WO 1999053950A3 US 9908530 W US9908530 W US 9908530W WO 9953950 A3 WO9953950 A3 WO 9953950A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- interferon
- live
- vaccines
- administering
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18171—Demonstrated in vivo effect
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99917611A EP1071453A2 (en) | 1998-04-17 | 1999-04-16 | Live vaccines and methods of treatment therewith |
AU35690/99A AU3569099A (en) | 1998-04-17 | 1999-04-16 | Live vaccines and methods of treatment therewith |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8219698P | 1998-04-17 | 1998-04-17 | |
US60/082,196 | 1998-04-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1999053950A2 WO1999053950A2 (en) | 1999-10-28 |
WO1999053950A3 true WO1999053950A3 (en) | 2000-01-13 |
WO1999053950A9 WO1999053950A9 (en) | 2000-07-13 |
Family
ID=22169653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/008530 WO1999053950A2 (en) | 1998-04-17 | 1999-04-16 | Live vaccines and methods of treatment therewith |
Country Status (4)
Country | Link |
---|---|
US (1) | US6506385B1 (en) |
EP (1) | EP1071453A2 (en) |
AU (1) | AU3569099A (en) |
WO (1) | WO1999053950A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02008254A (en) * | 2000-02-29 | 2003-02-06 | Wyeth Corp | In ovo protection against infectious bronchitis. |
US20010046500A1 (en) | 2000-02-29 | 2001-11-29 | Berend Jongsma | In ovo protection against infectious bronchitis |
AR031405A1 (en) * | 2000-11-21 | 2003-09-24 | Wyeth Corp | METHODS AND VACCINES TO CONFERENCE PROTECTION IN OVO AGAINST TURKEY'S RHINOTRACHISIS |
WO2003102246A1 (en) * | 2002-05-31 | 2003-12-11 | Penn State Research Foundation | Dot-elisa for the detection of animal viruses |
ES2417019T3 (en) | 2003-11-13 | 2013-08-05 | University Of Georgia Research Foundation, Inc. | Characterization procedure of infectious bursitis disease virus |
US7438019B2 (en) * | 2004-11-29 | 2008-10-21 | Compact Automation Products, Llc | Integrated pneumatic actuator and pump for dispensing controlled amounts of a fluid |
US20070178115A1 (en) | 2005-08-15 | 2007-08-02 | Tang De-Chu C | Immunization of avians by administration of non-replicating vectored vaccines |
KR20120042865A (en) | 2006-03-30 | 2012-05-03 | 엠브렉스, 인코포레이티드 | Methods and compositions for vaccination of poultry |
US8822192B2 (en) | 2009-05-12 | 2014-09-02 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Human rotavirus vaccine strains and diagnostics |
US10196616B2 (en) * | 2017-02-15 | 2019-02-05 | The United States Of America, As Represented By The Secretary Of Agriculture | Altered avian virus for in-ovo inoculation and methods of use thereof |
CN107299155B (en) * | 2017-08-18 | 2020-05-22 | 福建省农业科学院畜牧兽医研究所 | Primer and probe for real-time fluorescence quantitative PCR detection of goose astrovirus |
CN109762062B (en) * | 2018-09-19 | 2022-02-25 | 天津瑞普生物技术股份有限公司 | Preparation method of goose gout egg yolk antibody |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987004076A1 (en) * | 1985-12-30 | 1987-07-16 | The Texas A & M University System | Low dosage of interferon to enhance vaccine efficiency |
EP0609739A1 (en) * | 1993-02-02 | 1994-08-10 | American Cyanamid Company | Method of reversing immunosuppression in vaccines |
US5397568A (en) * | 1989-10-02 | 1995-03-14 | Whitfill; Craig E. | Method of treating infectious bursal disease virus infections |
WO1998037216A1 (en) * | 1997-02-21 | 1998-08-27 | Syntro Corporation | Recombinant chimeric viruses and uses thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053583A (en) | 1976-03-01 | 1977-10-11 | Smithkline Corporation | Live newcastle disease virus vaccines |
US5378457A (en) | 1981-12-24 | 1995-01-03 | Virogenetics Corporation | Interferon sensitive recombinant poxvirus vaccine |
US5910304A (en) | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
US5965138A (en) | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
US4689224A (en) | 1985-10-07 | 1987-08-25 | Neogen Corporation | Method for administering vaccines containing equine leukokines and compositions therefor |
JPH04506662A (en) | 1989-07-14 | 1992-11-19 | アメリカン・サイアナミド・カンパニー | Cytokinin and hormone carriers for conjugate vaccines |
US5562910A (en) | 1989-09-25 | 1996-10-08 | University Of Utah Research Foundation | Vaccine compositions and method for enhancing an immune response |
DK0584266T3 (en) | 1991-05-06 | 2003-12-29 | Us Gov Health & Human Serv | Recombinant virus expressing carcino embryonic antigen and methods for its use |
AUPN154295A0 (en) | 1995-03-06 | 1995-03-30 | Commonwealth Scientific And Industrial Research Organisation | Nucleic acid molecule encoding a protein with avian gamma-interferon activity |
US5562909A (en) | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
US5728385A (en) | 1993-08-12 | 1998-03-17 | Classen Immunotherapies, Inc. | Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
US5885567A (en) | 1993-10-22 | 1999-03-23 | University Of Connecticut | Treatment of infection in fowl by oral administration of avian interferon proteins |
US5605792A (en) | 1993-11-04 | 1997-02-25 | The Ohio State University Research Foundation | Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic |
US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
US5538733A (en) | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
US5705151A (en) | 1995-05-18 | 1998-01-06 | National Jewish Center For Immunology & Respiratory Medicine | Gene therapy for T cell regulation |
-
1999
- 1999-04-15 US US09/292,730 patent/US6506385B1/en not_active Expired - Fee Related
- 1999-04-16 EP EP99917611A patent/EP1071453A2/en not_active Withdrawn
- 1999-04-16 WO PCT/US1999/008530 patent/WO1999053950A2/en not_active Application Discontinuation
- 1999-04-16 AU AU35690/99A patent/AU3569099A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987004076A1 (en) * | 1985-12-30 | 1987-07-16 | The Texas A & M University System | Low dosage of interferon to enhance vaccine efficiency |
US5397568A (en) * | 1989-10-02 | 1995-03-14 | Whitfill; Craig E. | Method of treating infectious bursal disease virus infections |
EP0609739A1 (en) * | 1993-02-02 | 1994-08-10 | American Cyanamid Company | Method of reversing immunosuppression in vaccines |
WO1998037216A1 (en) * | 1997-02-21 | 1998-08-27 | Syntro Corporation | Recombinant chimeric viruses and uses thereof |
Non-Patent Citations (1)
Title |
---|
LOWENTHAL J W ET AL: "Coadministration of IFN -gamma enhances antibody responses in chickens.", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, vol. 18, no. 8, August 1998 (1998-08-01), pages 617 - 22, XP002122472 * |
Also Published As
Publication number | Publication date |
---|---|
AU3569099A (en) | 1999-11-08 |
WO1999053950A2 (en) | 1999-10-28 |
US6506385B1 (en) | 2003-01-14 |
EP1071453A2 (en) | 2001-01-31 |
WO1999053950A9 (en) | 2000-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ323973A (en) | Vaccine compositions for intranasal administration comprising chitosan and use thereof | |
WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
WO1999053950A3 (en) | Live vaccines and methods of treatment therewith | |
CA2339089A1 (en) | Cold-adapted equine influenza viruses | |
WO2001089559A3 (en) | Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine | |
HUP0401606A2 (en) | West nile vaccine | |
WO2005049074A3 (en) | Methods for modulating the th2 immuneresponse to an antigen by adding or removing activated carbonyl groups from the antigen | |
GB9306731D0 (en) | Vaccines | |
JP2003513935A5 (en) | ||
CA2115927A1 (en) | Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus | |
WO2001034189A3 (en) | Vaccines for mycoplasma bovis and methods of use | |
MX2011003535A (en) | Bovine herpes virus -1 compositions, vaccines and methods. | |
PT1015595E (en) | DERIVATIVE PEPTIDES OF LIGACAO (G) PROTEIN FROM RESPIRATORY SYNCYCIAL VIRUS | |
MXPA02005506A (en) | Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens. | |
AU2005244826B2 (en) | Treatment or prevention of respiratory viral infections with immunomodulator compounds | |
CA2463090A1 (en) | Recombinant rabies vaccine and methods of preparation and use | |
US8105613B2 (en) | Vaccine formulation | |
FI932759A (en) | ADJUSTMENT OF IL-4 FOR OVERNING AV PAO VACCINERS IMMUNOGENER VERKANDE IMMUNREAKTIONER | |
WO2001064244A3 (en) | In ovo protection against infectious bronchitis | |
WO2007135420A3 (en) | Defective interfering virus | |
WO2004030614A3 (en) | Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor | |
WO2004100640A3 (en) | Marek’s disease virus vaccine | |
US6383741B2 (en) | Method for treatment of canine distemper | |
IL122829A (en) | Isolated strains of staphylococcus aureus and vaccines manufactured therefrom | |
WO2001045642A3 (en) | Pulmonary delivery of ribavirin or levovirin™ for systemic and quasi-systemic treatment of disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-36, DESCRIPTION, REPLACED BY NEW PAGES 1-36; PAGES 37-44, CLAIMS, REPLACED BY NEW PAGES 37-44; PAGES 1/11-11/11, DRAWINGS, REPLACED BY NEW PAGES 1/11-11/11; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999917611 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999917611 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999917611 Country of ref document: EP |